Academic Journal
Q3Cold Spring Harbor Molecular Case Studies
About Cold Spring Harbor Molecular Case Studies
About Cold Spring Harbor Molecular Case Studies
Cold Spring Harbor Molecular Case Studies is a peer-reviewed scholarly journal published by 210 (United States). It focuses on Q3. Publication coverage spans 2016-2023.
Key indicators: ISSN 2373-2873; H-index 31.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (31): 31 articles have each received at least 31 citations, indicating growing recognition.
Publishing in Cold Spring Harbor Molecular Case Studies
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Scope fit: Confirm your research aligns with Q3. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Cold Spring Harbor Molecular Case Studies?
2373-2873.
Who publishes Cold Spring Harbor Molecular Case Studies?
210.
What are Cold Spring Harbor Molecular Case Studies's metrics?
H-index 31.
Where do I submit to Cold Spring Harbor Molecular Case Studies?
Via the official website.
Is Cold Spring Harbor Molecular Case Studies peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Genomics and Rare Diseases; Cancer Genomics and Diagnostics; Genetics and Neurodevelopmental Disorders; Genomic variations and chromosomal abnormalities; Genetic factors in colorectal cancer; RNA modifications and cancer.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Health supervision for children and adolescents with 16p11.2 deletion syndrome
Wendy K. Chung, Faranak F. Herrera
2023-12 · DOI: 10.1101/mcs.a006316Common clonal origin of three distinct hematopoietic neoplasms in a single patient: B-cell lymphoma, T-cell lymphoma, and polycythemia vera
Dingani Nkosi, Andrew W. Allbee, Paul G. Rothberg, Jonathan W. Friedberg et al.
2023-12 · DOI: 10.1101/mcs.a006313PD-L1+diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquiredPMS2mutation
Andrew W. Allbee, James Gerson, Guang Yang, Adam Bagg et al.
2023-12 · DOI: 10.1101/mcs.a006318The diagnostic odyssey of a patient with dihydropyrimidinase deficiency: a case report and review of the literature
Daniah Albokhari, Ohood Alharbi, Alyssa Blesson, Mahim Jain et al.
2023-12 · DOI: 10.1101/mcs.a006319Clinical and functional analysis of the germlineTP53p.K164E acetylation site variant
Emilia Modolo Pinto, Enilze M.S.F. Ribeiro, Jinling Wang, Aaron H. Phillips et al.
2023-12 · DOI: 10.1101/mcs.a006290Prostate cancer patient stratification by molecular signatures in the Veterans Precision Oncology Data Commons
Kyle M. Hernandez, Aarti Venkat, Danne C. Elbers, John R. Bihn et al.
2023-12 · DOI: 10.1101/mcs.a006298Pazopanib elicits remarkable response in metastatic porocarcinoma: a functional precision medicine approach
Sharon Pei Yi Chan, Chen Ee Low, Chun En Yau, Tzu Ping Lin et al.
2023-12 · DOI: 10.1101/mcs.a006308Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germlineSMARCA4andEZH2variants
Pauline Tibout, Joel Livingston, Nisha Kanwar, Kyoko E. Yuki et al.
2023-12 · DOI: 10.1101/mcs.a006286Deep molecular tracking over the 12-yr development of endometrial cancer from hyperplasia in a single patient
Katherine Reid, Olga Camacho-Vanegas, Deep Pandya, Sandra Catalina Camacho et al.
2023-12 · DOI: 10.1101/mcs.a006311ITPR1-associated spinocerebellar ataxia with craniofacial features—additional evidence for germline mosaicism
Robert Kleyner, Nathaniel Ung, Mohammad Arif, Elaine Marchi et al.
2023-12 · DOI: 10.1101/mcs.a006303Novel inheritedCDX2variant segregating in a family with diverse congenital malformations of the genitourinary system
Swetha Ramadesikan, Caitlyn M. Colwell, Rachel Supinger, Jesse Hunter et al.
2023-12 · DOI: 10.1101/mcs.a006294Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL)
Patricia M. Kim, Reza Nejati, Pin Lu, Devang Thakkar et al.
2023-12 · DOI: 10.1101/mcs.a006283Novel pathogenicUQCRC2variants in a female with normal neurodevelopment
Lea Abou Haidar, Robert C. Harris, Panayotis Pachnis, Hongli Chen et al.
2023-12 · DOI: 10.1101/mcs.a006295De novoTRPM3missense variant associated with neurodevelopmental delay and manifestations of cerebral palsy
Jagadish Chandrabose Sundaramurthi, Anita M. Bagley, Hannah Blau, Leigh Carmody et al.
2023-12 · DOI: 10.1101/mcs.a006293The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer
Majd Al Assaad, Gunes Gundem, Benjamin Liechty, Andrea Sboner et al.
2023-12 · DOI: 10.1101/mcs.a006275Novel pathogenicPDX1gene variant in a Korean family with maturity-onset diabetes of the young
Hyunji Kim, Hwa Young Kim, Jae Hyun Kim, Soo Hyun Seo et al.
2023-12 · DOI: 10.1101/mcs.a006305Reclassification of theHPGDp.Ala13Glu variant causing primary hypertrophic osteoarthropathy
Juan J. Alban, Alejandra Arango-Ramirez, Jorge A. Olave-Rodriguez, Jose A. Nastasi-Catanese et al.
2023-12 · DOI: 10.1101/mcs.a006291Rapid genome diagnosis of alveolar capillary dysplasia leading to treatment in a child with respiratory and cardiac failure
Dana R. Tower, Ronald W. Day, Tighe Marrone, Rachel Palmquist et al.
2023-12 · DOI: 10.1101/mcs.a006292Evaluation of hypereosinophilia in a case ofFLT3-mutant acute myeloid leukemia treated with gilteritinib
Leslie N. Martinez-Gutierrez, Blake C. Burgher, Manuel J. Glynias, Daniel Alvarado et al.
2023-06 · DOI: 10.1101/mcs.a006279Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care
Alexis D. Levine, Wendy K. Chung
2023-06 · DOI: 10.1101/mcs.a006285Reviews
Community Reviews
Version History
October 10, 2026 at 2:18 am
October 2, 2026